Significant Insider Sales in Shares of Immunogen (IMGN) Extends the Selling Trend of Last Quarter

Friday, February 23, 2018 10:15 PM ET

Significant Insider Sales in Shares of Immunogen (IMGN) Extends the Selling Trend of Last Quarter

A substantial level of insider sales in Immunogen was reported in form 4 documents filed with the SEC today. Eight insiders listed below, disposed of 191,058 shares in the company having a market value of approximately $2,090,942. There have been 2 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been sales resulting in the disposition of 27,904 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 218,962 shares and have averaged 21,896 shares per transaction over this time period.

Over the last 90 days, the number of insider buy/sell trades at Immunogen is greater than its 191-company peer group average. The Biotechnology & Medical Research peer group saw 169 buy/sell trades during this period for an average of 0.9 transactions per company. However, the number of shares traded per transaction by Immunogen insiders is lower than its peers. Within the peer group there were 11,430,304 shares purchased and 12,701,114 shares sold with company insiders disposing of 7,520 shares on average over this time period.

To bring into focus significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated in data used to evaluate and write this story.

Today’s Insider Activity
* Daniel M Junius, Director, sold 11,713 shares
* Craig Barrows, Officer, sold 15,498 shares
* David Brannon Johnston, Officer, sold 21,060 shares
* Dr Theresa Wingrove, Officer, sold 11,379 shares
* Mark J Enyedy, Director and Officer, sold 67,717 shares
* Richard J Gregory, Officer, sold 34,486 shares
* Dr Anna Berkenblit, Officer, sold 17,329 shares
* Thomas Ryll, Officer, sold 11,876 shares

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.